Who is sponsoring NCT01090518?

NCT01090518 is sponsored by Bronx VA Medical Center.

What drugs are being tested in NCT01090518?

Interventions: Prolonged Exposure therapy, Hydrocortisone, Prolonged Exposure therapy.

What is the status of NCT01090518?

NCT01090518 is currently UNKNOWN.

Last reviewed 2013-02-04 · How we verify

Cortisol Augmentation of a Psychological Treatment in Warfighters With Post Traumatic Stress Disorder (PTSD)

NCT01090518 NA UNKNOWN

This study seeks to examine the efficacy of hydrocortisone administration in the augmentation of the therapeutic effects of Prolonged Exposure (PE) therapy, an empirically tested treatment shown to be effective in the the treatment of posttraumatic stress disorder (PTSD). The augmentation builds on both the translation of neuroscience findings demonstrating the effects of glucocorticoids (GCs) on learning, and on empirical clinical findings from other investigators demonstrating beneficial effects of GCs in reducing traumatic memories in trauma-exposed persons.

Details

Lead sponsor	Bronx VA Medical Center
Phase	NA
Status	UNKNOWN
Enrolment	50
Start date	2010-02

Conditions

PTSD

Interventions

Prolonged Exposure therapy
Hydrocortisone
Prolonged Exposure therapy

Primary outcomes

PTSD symptom severity as assessed by the Clinician Administered PTSD Scale (CAPS) — week 0
PTSD symptom severity as assessed by the Clinician Administered PTSD Scale (CAPS) — week 10
PTSD symptom severity as assessed by the Clinician Administered PTSD Scale (CAPS) — week 16

Countries

United States